Gergen Mark J

Gergen Mark J is listed in filings as President and CEO at Poseida Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 8, 2025, including sale activity. Recent filings connect the profile to Poseida Therapeutics, Inc. (PSTX). The current snapshot covers public activity from Nov 27, 2024 to Jan 8, 2025. Reported amounts are shown as $5.7M to $2.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.